Endocannabinoid
Resource Center
TOP ARTICLES
Cannabis May Not Be Right for Everyone – and That’s Okay
It’s true that not all cannabis products are right for everyone and, therefore cannot be used to treat everyone in the same way. We all have an endocannabinoid system, which is our primary regulatory system and we produce our own endogenous endocannabinoids. When the body has certain deficiencies in endogenous
Actual THC or CBD Content is Often Different from What Consumers Expect, says JAMA Study
A buyer-beware study, from Massachusetts General Hospital (MGH), shows that medical cannabis products may be poorly labeled and do not always represent accurate levels of actual THC or CBD content. The JAMA Network Open study points out that this can be particularly important when the psychoactive metabolite Δ9-tetrahydrocannabinol (THC), the
Experimental Mice Study Shows CBD May Reduce Plaque and Improve Cognition in Familial Alzheimer’s Model
Just as FDA is a new months away from making a ruling on the new drug aducanaumab that is reported to clear amyloid plaque, an experimental mouse study in the Journal of Alzheimer’s Disease shows that a two-week course of CBD may reduce plaque and improve cognition. Researchers tested a
Could CBD Reduce COVID Lung Damage? A Protective Peptide May Be the Answer
New research shows that CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of
Cannabis Users Need More Anesthesia During Surgery and Opioids in Recovery
Not only might cannabis users need more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while in the hospital, suggests first-of-its kind research being presented at the ANESTHESIOLOGY® 2020 annual meeting. Adding to the growing body of research that shows patients
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice
Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at a higher risk of developing colorectal cancer. In a recent study published in iScience by authors from the University of South Carolina, it was shown
Systematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain, according to the study published in Cannabis
